| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $135.9M | -23.1% |
| Cost of Revenue | $89.0M | -21.6% |
| Gross Profit | $46.9M | -25.8% |
| R&D Expense | $4.1M | +30.8% |
| SG&A Expense | $62.3M | +1.7% |
| Operating Income | -$19.5M | +26.0% |
| Pre-tax Income | -$30.2M | +18.9% |
| Income Tax | -$1.9M | -202.3% |
| Net Income | -$28.3M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.0M | -53.6% |
| Accounts Receivable | $18.3M | -37.9% |
| Inventory | $43.3M | -2.0% |
| Current Assets | $78.4M | -21.9% |
| Total Assets | $115.3M | -27.3% |
| Current Liabilities | $77.0M | +66.6% |
| Long-term Debt | $37.1M | -7.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$439K | -103.8% |
| Investing Cash Flow | -$506K | +61.7% |
| Financing Cash Flow | -$7.1M | +10.9% |
| +27.6% |
| EPS (Basic) | -$15.11 | -253.0% |
| EPS (Diluted) | -$15.11 | -253.0% |
| Total Liabilities |
| $99.7M |
| -12.0% |
| Stockholders' Equity | -$12.9M | -177.0% |